Search alternatives:
d cases » _ causes (Expand Search)
decrease » increase (Expand Search)
increased » increase (Expand Search)
Showing 121 - 140 results of 278 for search '(( i largest decrease ) OR ( d cases increased ))*', query time: 0.10s Refine Results
  1. 121

    Renin–angiotensin-system gene polymorphisms and depression by Saab, Yolande B.

    Published 2007
    “…The frequencies of common polymorphisms of genes encoding for components of the RAS, namely angiotensinogen (M235T), angiotensin converting enzyme (ACE) (insertion, I; deletion, D), angiotensin receptor type I (A1166C), and angiotensin receptor type II (C3123A) were determined in DNA extracted from buccal cells from a Lebanese population of 132 depressed patients and their first-degree relative case-controls. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  2. 122
  3. 123

    Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021 by Eduardo, Bernabe

    Published 2025
    “…Furthermore, DALY rates of lip and oral cavity cancer decreased in the European region and the region of the Americas, while DALY rates of orofacial clefts decreased in all regions. …”
    Get full text
    Get full text
    Get full text
    article
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130

    Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review by Eihab A. Subahi (12217761)

    Published 2022
    “…However, there are increasingly reported cases of EMH in BTM. The incidence of EMH in BTM is thought to be <1%. …”
  11. 131

    Validation of Polygenic Risk Scores for Coronary Heart Disease in a Middle Eastern Cohort Using Whole Genome Sequencing by Mohamad Saad (214545)

    Published 2022
    “…Six suggestive (<i>P</i><10−5) new loci/genes with plausible biological function were identified (eg, <i>CORO7</i>, <i>RBM47</i>, <i>PDE4D</i>). The burden of rare functional variants in <i>LDLR</i>, <i>APOB</i>, <i>PCSK9</i>, and <i>ANGPTL4</i> was greater in cases than controls.…”
  12. 132

    Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19 by Abu Saleh Md Moin (6189512)

    Published 2021
    “…The objective was to determine the circulatory biomarkers for macrophage activation at baseline and after serum glucose normalization in obese type 2 diabetes (OT2D) subjects. A case-controlled interventional pilot study in OT2D (n = 23) and control subjects (n = 23). …”
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140